Literature DB >> 12598223

Ipratropium and lung health study.

Stephan Lanes, Wolfgang Golisch, Jaromir Mikl.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12598223     DOI： 10.1164/ajrccm.167.5.955

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  4 in total

Review 1.  Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2012-01-22       Impact factor: 9.546

Review 2.  Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date.

Authors:  Yoon K Loke; Sonal Singh
Journal:  Ther Adv Drug Saf       Date:  2012-06

3.  Do inhaled anticholinergics increase or decrease the risk of major cardiovascular events?: a synthesis of the available evidence.

Authors:  Shelley R Salpeter
Journal:  Drugs       Date:  2009-10-22       Impact factor: 9.546

Review 4.  Tiotropium HandiHaler in the treatment of COPD: a safety review.

Authors:  Steven Kesten; Bart Celli; Marc Decramer; Inge Leimer; Donald Tashkin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.